Randomized controlled trial of physician-directed versus Respiratory Therapy Consult service-directed respiratory care to adult non-ICU inpatients.
Although current evidence suggests that respiratory care protocols can enhance allocation of respiratory care services while conserving costs, a randomized trial is needed to address shortcomings of available studies.
We therefore conducted a randomized controlled trial comparing respiratory care for adult non-ICU inpatients directed by a Respiratory Therapy Consult Service (RTCS) versus respiratory care by managing physicians.
Eligible subjects were adult non-ICU inpatients whose physicians had prescribed specific respiratory care services.
Consecutive eligible patients were approached for consent, after which a blocked randomization strategy was used to assign patients to (1) Physician-directed respiratory care, in which the prescribed physician respiratory care orders were maintained (n=74), or (2) RTCS-directed respiratory care, in which the physician's respiratory care orders were preempted by a respiratory care plan generated by the RTCS (n=71).
Specifically, these patients were evaluated by an RTCS therapist evaluator whose respiratory care plan was based on sign/symptom-based algorithms drafted to comply with the American Association for Respiratory Care (AARC) Clinical Practice Guidelines.
Appropriateness of respiratory care orders was assessed as agreement between the prescribed respiratory care plan and an algorithm-based « standard care plan » generated by an expert therapist who was blind to the patient's actual orders. (...)
Mots-clés Pascal : Soin, Appareil respiratoire, Appareil respiratoire pathologie, Essai thérapeutique contrôlé, Médecin, Conseil, Analyse coût, Economie santé, Oxygénothérapie, Bronchodilatateur, Etude comparative, Traitement, Pronostic, Homme
Mots-clés Pascal anglais : Care, Respiratory system, Respiratory disease, Controlled therapeutic trial, Physician, Council, Cost analysis, Health economy, Oxygenotherapy, Bronchodilator, Comparative study, Treatment, Prognosis, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0498734
Code Inist : 002B11D. Création : 19/02/1999.